The SCOPE US conference in early February brought together industry leaders to explore the evolving landscape of clinical research, with technology taking center stage. From AI-driven trial design to advanced data analytics and decentralized trial solutions, innovation is reshaping how...
Site selection is a pivotal phase in the planning of clinical trials. The right sites ensure timely recruitment, high-quality data, and overall study success. To make informed decisions, leveraging multiple data sources is essential for maximizing opportunity and mitigating risk. ...
In rare diseases, patient opinion and insight often go unheard. However, for sponsors of rare disease clinical trials, study success often rests on incorporating the patient perspective as early as possible in development. Many patients with rare diseases have undertaken...
Recruitment for rare disease research has always been difficult due to myriad factors inherent to the low incidence and prevalence of these conditions. In recent years, however, recruiting for rare disease trials has become even more challenging due to increasing...
Minimizing the burden that trial participants experience is essential for successful recruitment and retention, especially in oncology studies, where patients may need to be followed for years after the treatment phase of the trial. For sponsors, the process of optimizing...
During the initial planning for clinical trial implementation, intense focus is placed on strategies for patient recruitment, while strategies for patient engagement and retention are often left until after the treatment phase. However, with many current protocol designs in oncology,...